Manual of Adolescent Substance Abuse Treatment

319 Pages·2001·1.38 MB·English

by  Todd Wilk

Manual of Adolescent
Substance Abuse
Treatment
This page intentionally left blank
Manual of Adolescent
Substance Abuse
Treatment
Edited by
Todd Wilk Estroff, M.D.
Washington, DC
London, England
Note: The authors have worked to ensure that all information in this book
concerning drug dosages, schedules, and routes of administration is accurate
as of the time of publication and consistent with standards set by the U.S.
Food and Drug Administration and the general medical community. As
medical research and practice advance, however, therapeutic standards may
change. For this reason and because human and mechanical errors sometimes
occur, we recommend that readers follow the advice of a physician who is
directly involved in their care or the care of a member of their family. A
product’s current package insert should be consulted for full prescribing and
safety information.
Books published by the American Psychiatric Publishing, Inc., represent the
views and opinions of the individual authors and do not necessarily represent
the policies and opinions of the Press or the American Psychiatric Association.
Copyright © 2001 American Psychiatric Publishing, Inc.
ALL RIGHTS RESERVED
Manufactured in the United States of America on acid-free paper
04 03 02 01 4 3 2 1
First Edition
American Psychiatric Publishing, Inc.
1400 K Street, N.W.
Washington, DC 20005
www.appi.org
Library of Congress Cataloging-in-Publication Data
Manual of adolescent substance abuse treatment / edited by Todd Wilk
Estroff.-- 1st ed.
p. cm.
Includes bibliographical references and index.
ISBN 0-88048-712-7
1. Substance abuse--Treatment. 2. Teenagers--Substance use. 3.
Teenagers--Drug use. 4. Drug abuse--Treatment. I. Estroff, Todd Wilk.
RJ506.D78 M36 2001
616.86’06’0835--dc21
2001022179
British Library Cataloguing in Publication Data
A CIP record is available from the British Library.
Contents
Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Acknowledgements . . . . . . . . . . . . . . . . . . . . . . . xi
1
Epidemiology . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Patricia A. Harrison, Ph.D.
2
Predisposing Factors . . . . . . . . . . . . . . . . . . . . . .13
Patricia A. Harrison, Ph.D.
3
Routes of Abuse and Specific Drugs . . . . . . . . . . .35
Todd Wilk Estroff, M.D.
4
Diagnosis of Adolescent
Substance Abuse Disorders. . . . . . . . . . . . . . . . . .51
Peter R. Cohen, M.D.
Todd Wilk Estroff, M.D.
5
Comorbidity and Adolescent
Substance Abuse. . . . . . . . . . . . . . . . . . . . . . . . .69
Oscar G. Bukstein, M.D., M.P.H.
6
Medical Evaluation of
Substance-Abusing Adolescents . . . . . . . . . . . . . .91
Anthony H. Dekker, D.O.
Todd Wilk Estroff, M.D.
Norman G. Hoffmann, Ph.D.
7
Psychiatric and Substance Abuse
Evaluation of Adolescents . . . . . . . . . . . . . . . . . .99
R. Jeremy A. Stowell, M.D.
Todd Wilk Estroff, M.D.
8
Treatment Planning and Case Management . . . . .129
Linda Semlitz, M.D.
9
Outpatient Treatment . . . . . . . . . . . . . . . . . . . .155
Todd Wilk Estroff, M.D.
10
Inpatient Programs . . . . . . . . . . . . . . . . . . . . . .165
R. Jeremy A. Stowell, M.D.
Todd Wilk Estroff, M.D.
11
Use of Medications
With Substance-Abusing Adolescents . . . . . . . . .187
Steven L. Jaffe, M.D.
Todd Wilk Estroff, M.D.
12
Adolescent Psychiatry and 12-Step Treatment . . .205
J. Calvin Chatlos, M.D.
Todd Wilk Estroff, M.D.
13
Spirituality. . . . . . . . . . . . . . . . . . . . . . . . . . . .229
Martha A. Morrison, M.D.
Norman G. Hoffmann, Ph.D.
Sara S. DeHart, Ph.D.
Todd Wilk Estroff, M.D.
Paul King, M.D.
14
Family Treatment . . . . . . . . . . . . . . . . . . . . . . .235
Susan D. Wallace
Todd Wilk Estroff, M.D.
15
Relapse . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .253
Steven L. Jaffe, M.D.
Todd Wilk Estroff, M.D.
16
Adolescent Development and Substance Abuse . .265
Stuart A. Copans, M.D.
Jean Kinney, M.S.W.
Todd Wilk Estroff, M.D.
17
Untreatable Substance-Abusing Adolescents . . . .273
Todd Wilk Estroff, M.D.
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .285
This page intentionally left blank
Contributors
Oscar G. Bukstein, M.D., M.P.H.
Associate Professor of Psychiatry, Department of Psychiatry, Western
Psychiatric Institute and Clinic, University of Pittsburgh School of
Medicine, Pittsburgh, Pennsylvania
J. Calvin Chatlos, M.D.
Director, Substance Abuse Services, Carrier Clinic, Belle Meade, New Jersey
Peter R. Cohen, M.D.
Medical Director, Behavioral Health Services, Washington County Hospital
System, Hagerstown, Maryland
Stuart A. Copans, M.D.
Adjunct Associate Professsor, Department of Psychiatry, Dartmouth
Medical School, Brattleboro, Vermont
Sara S. DeHart, Ph.D.
Affiliate Associate Professor, School of Nursing, University of Washington,
Seattle, Washington
Anthony H. Dekker, D.O.
Associate Director, Phoenix Indian Medical Center; Director, Ambulatory
Care and Community Health, Phoenix, Arizona
Todd Wilk Estroff, M.D.
Private practice, Atlanta Georgia
Patricia A. Harrison, Ph.D.
Co-Director, Health Care Research Division, Minnesota Department of
Human Services, St. Paul, Minnesota
ix